Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
GE HealthCare Technologies Inc.
Report date February 09, 2023 · Filed December 29, 2023
Section 16 reporting ended · disclosed 2023-12-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 66,887 |
Reported balance
After 2023-02-09 transaction · row 1
1 source rowRow 1 · 2023-02-09 · Grant · Acquired 13,878 · Balance 66,887 F1: Inadvertently filed late due to an administrative error. F2: Performance stock units ("PSUs") granted on March 1, 2021 by General Electric Company ("GE") prior to the January 3, 2023 distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") to holders of GE common stock on a pro rata basis. The applicable performance criteria were satisfied and certified by GE's Management Development and Compensation Committee on February 9, 2023. Each PSU represents the right to receive, at settlement, one share of GE HealthCare common stock. The PSUs vest on March 1, 2024, subject to the reporting person's continued employment. |
Filing footnotes · ownership attribution and instrument terms
F1: Inadvertently filed late due to an administrative error.
F2: Performance stock units ("PSUs") granted on March 1, 2021 by General Electric Company ("GE") prior to the January 3, 2023 distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") to holders of GE common stock on a pro rata basis. The applicable performance criteria were satisfied and certified by GE's Management Development and Compensation Committee on February 9, 2023. Each PSU represents the right to receive, at settlement, one share of GE HealthCare common stock. The PSUs vest on March 1, 2024, subject to the reporting person's continued employment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2023 Filed Apr 3, 2023 20:06 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 3,448 | $82.12 | $283,149.76 |
DisclosureSEC source: 0001628280-23-010383 · wf-form4_168055237917989.xml · nonDerivative · entry 1 Zodl Helmut · CIK 0001951654 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,009 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 27,788 | $0.00 Strike: $75.30 | $0.00 |
DisclosureSEC source: 0001628280-23-006432 · wf-form4_167789121158710.xml · derivative · entry 3 Zodl Helmut · CIK 0001951654 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,788 Underlying: Common Stock, par value $0.01 per share · 27,788 shares Expires 2033-03-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,778 | $75.30 | $133,883.40 |
DisclosureSEC source: 0001628280-23-006432 · wf-form4_167789121158710.xml · nonDerivative · entry 2 Zodl Helmut · CIK 0001951654 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,457 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:53 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 9,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006432 · wf-form4_167789121158710.xml · nonDerivative · entry 1 Zodl Helmut · CIK 0001951654 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,235 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| February 09, 2023 Filed Dec 29, 2023 23:00 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 13,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-042945 · wk-form4_1703890837.xml · nonDerivative · entry 1 Zodl Helmut · CIK 0001951654 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,887 F1 · date: Inadvertently filed late due to an administrative error. F2 · shares: Performance stock units ("PSUs") granted on March 1, 2021 by General Electric Company ("GE") prior to the January 3, 2023 distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") to holders of GE common stock on a pro rata basis. The applicable performance criteria were satisfied and certified by GE's Management Development and Compensation Committee on February 9, 2023. Each PSU represents the right to receive, at settlement, one share of GE HealthCare common stock. The PSUs vest on March 1, 2024, subject to the reporting person's continued employment. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 23:03 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 47,031 | Not disclosed Strike: $70.01 | Not disclosed |
DisclosureSEC source: 0001628280-23-002270 · wf-form4_167546539828224.xml · derivative · entry 2 Zodl Helmut · CIK 0001951654 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,031 Underlying: Common Stock, par value $0.01 per share · 47,031 shares Expires 2033-02-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 23:03 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 5,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-002270 · wf-form4_167546539828224.xml · nonDerivative · entry 1 Zodl Helmut · CIK 0001951654 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,275 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 5,356 newly awarded restricted stock units and 42,919 previously reported restricted stock units. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:39 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 11,654 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001102 · doc4.xml · derivative · entry 4 Zodl Helmut · CIK 0001951654 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,654 Underlying: Common stock, par value $0.01 per share · 11,654 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of GE HealthCare Technologies Inc. ("GE HealthCare"). F5 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. F5 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. F5 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:39 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 1,990 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001102 · doc4.xml · derivative · entry 3 Zodl Helmut · CIK 0001951654 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,990 Underlying: Common stock, par value $0.01 per share · 1,990 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of GE HealthCare Technologies Inc. ("GE HealthCare"). F4 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on June 1, 2023 and 50% will vest on June 1, 2024. F4 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on June 1, 2023 and 50% will vest on June 1, 2024. F4 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on June 1, 2023 and 50% will vest on June 1, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:39 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 17,397 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001102 · doc4.xml · derivative · entry 2 Zodl Helmut · CIK 0001951654 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,397 Underlying: Common stock, par value $0.01 per share · 17,397 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of GE HealthCare Technologies Inc. ("GE HealthCare"). F3 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on April 1, 2023 and 50% will vest on April 1, 2024. F3 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on April 1, 2023 and 50% will vest on April 1, 2024. F3 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on April 1, 2023 and 50% will vest on April 1, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:39 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 11,878 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001102 · doc4.xml · derivative · entry 1 Zodl Helmut · CIK 0001951654 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,878 Underlying: Common stock, par value $0.01 per share · 11,878 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock of GE HealthCare Technologies Inc. ("GE HealthCare"). F2 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024. F2 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024. F2 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.